MEDPvsTMO
Medpace Holdings IncvsThermo Fisher Scientific Inc. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.
Medpace Holdings Inc
$393.42
-29.59%
Thermo Fisher Scientific Inc
$513.98
-11.21%
60-day price, rebased to 100
Round-by-round
Valuation upside
+23.40% vs -44.40% to DCF fair value
Balance-sheet strength
Altman Z 7.23 vs 3.47
Fundamental quality
Piotroski 6.00 vs 5.00 (of 9)
Growth + margins
Rule-of-40 46.90 vs 18.00
60-day momentum
-32.46% vs -17.62% price return
Market-cap liquidity
$14.1B vs $182.3B
Verdict
Across6categories,MEDPtakes the edge with4wins to2. Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.
Backtest a strategy onMEDPorTMO
Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.